A Phase II Window-of-opportunity Study of Preoperative Therapy With Pazopanib (Votrient) in High-risk Soft Tissue Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Biomarker; Therapeutic Use
- Acronyms NOPASS
- 20 Jan 2017 This trial was discontinued in Germany (end date: 2016-12-31), according to European Clinical Trials Database.
- 30 Jan 2014 According to ClinicalTrials.gov record, planned End Date changed from 1 Nov 2016 to 1 Jun 2018.
- 28 May 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-003745-18).